GTG price jumps on Applera lawsuit news
Thursday, 16 September, 2004
The share price of Genetic Technologies (ASX: GTG) jumped 25 per cent today on heavy trading after the company announced that the judge in GTG's lawsuit against Applera had ruled largely in the company's favour during the Markman hearing, in which the court rules on the precise meanings of certain disputed technical terms within GTG's patent claims.
Out of 15 disputed terms, the court ruled in favour of GTG's definition in 13 cases, and for the remaining two terms, the court adopted a definition consistent with GTG's position.
At the time of writing, GTG's shares were trading at AUD$0.475, up from a previous close of $0.38.
Link between oestrogen and heart health found in women
Scientists found that oestrogen helps increase the ANXA1 protein, and when ANXA1 is missing, the...
Frequent nightmares accelerate aging, increase risk of death
Nghtmares independently predict faster biological aging and earlier mortality — even after...
Cardiac organoids bring hope for treating heart disease
Australian scientists have developed lab-grown, three-dimensional heart tissues known as cardiac...
